Christopher K. Cote

2.7k total citations
96 papers, 1.9k citations indexed

About

Christopher K. Cote is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Christopher K. Cote has authored 96 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 49 papers in Genetics and 28 papers in Epidemiology. Recurrent topics in Christopher K. Cote's work include Bacillus and Francisella bacterial research (49 papers), Yersinia bacterium, plague, ectoparasites research (27 papers) and Burkholderia infections and melioidosis (26 papers). Christopher K. Cote is often cited by papers focused on Bacillus and Francisella bacterial research (49 papers), Yersinia bacterium, plague, ectoparasites research (27 papers) and Burkholderia infections and melioidosis (26 papers). Christopher K. Cote collaborates with scholars based in United States, Italy and Canada. Christopher K. Cote's co-authors include Susan L. Welkos, Joel A. Bozue, Nico van Rooijen, Christopher P. Klimko, Patricia L. Worsham, Allen L. Honeyman, Kei Amemiya, Arthur M. Friedlander, Krishna-Sulayman Moody and Amy Jenkins and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Christopher K. Cote

93 papers receiving 1.9k citations

Peers

Christopher K. Cote
Comparison fields: 5 of 99
  • Molecular Biology 1.2k
  • Genetics 689
  • Ecology 356
  • Epidemiology 333
  • Infectious Diseases 302
Joel A. Bozue United States
Mark Eppinger United States
Kimberly M. Brothers United States
Guntram A. Graßl Germany
Gwennaële Fichant France
Sören Abel United States
Vartul Sangal United Kingdom
Lionel Dubost France
Masahisa Watarai Japan
M. J. Rosovitz United States
Joel A. Bozue United States View profile →
Citations per field, relative to Christopher K. Cote
Christopher K. Cote · 1×
Citations per year, relative to Christopher K. Cote
Christopher K. Cote · 1×

Countries citing papers authored by Christopher K. Cote

Since Specialization
Citations

This map shows the geographic impact of Christopher K. Cote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. Cote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. Cote more than expected).

Fields of papers citing papers by Christopher K. Cote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher K. Cote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. Cote. The network helps show where Christopher K. Cote may publish in the future.

Co-authorship network of co-authors of Christopher K. Cote

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher K. Cote. A scholar is included among the top collaborators of Christopher K. Cote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher K. Cote. Christopher K. Cote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases ACS Infectious Diseases Jennifer Chua, Christopher P. Klimko et al. 1
2 Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer rats Microbial Pathogenesis J. Matthew Meinig, Robert P. Edwards et al. 0
3 Efficacy of delafloxacin against the biothreat pathogenBacillus anthracis Journal of Antimicrobial Chemotherapy Sandra P. McCurdy, Randall Hoover et al. 4
4 Live attenuated vaccines and layered defense strategies to combat infections caused by nonencapsulated Yersinia pestis Christopher P. Klimko, Jennifer L. Shoe et al. 4
5 The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei Antibiotics Michelle Nelson, Carwyn Davies et al. 6
6 Investigating the fate of polycyclic aromatic sulfur heterocycle compounds in spilled oils with a microcosm weathering experiment SHILAP Revista de lepidopterología Pamela Brunswick, Christopher K. Cote et al. 7
7 Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei Microbial Pathogenesis David M. Waag, Taylor Chance et al. 6
8 Development, Phenotypic Characterization and Genomic Analysis of a Francisella tularensis Panel for Tularemia Vaccine Testing Frontiers in Microbiology Joshua B. Richardson, Christopher P. Klimko et al. 6
9 Anthrax toxin component, Protective Antigen, protects insects from bacterial infections PLoS Pathogens Luis O. González, Christopher P. Klimko et al. 8
10 Combinations of early generation antibiotics and antimicrobial peptides are effective against a broad spectrum of bacterial biothreat agents Microbial Pathogenesis Christopher K. Cote, Jennifer L. Shoe et al. 25
11 Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness Frontiers in Microbiology Fabrice Biot, G. I. Koroleva et al. 21
12 A Francisella novicida Mutant, Lacking the Soluble Lytic Transglycosylase Slt, Exhibits Defects in Both Growth and Virulence Frontiers in Microbiology Jennifer Chua, Christopher K. Cote et al. 10
13 AvirulentBacillus anthracisStrain with Molecular Assay Targets as Surrogate for Irradiation-Inactivated Virulent Spores Emerging infectious diseases Roger D. Plaut, Mark A. Munson et al. 1
14 Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences PLoS ONE April A. Shea, Christopher K. Cote et al. 9
15 Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice Frontiers in Cellular and Infection Microbiology Joel A. Bozue, Sidhartha Chaudhury et al. 12
16 Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice Microbial Pathogenesis Kei Amemiya, David P. Fetterer et al. 17
17 A Unique Set of the Burkholderia Collagen-Like Proteins Provides Insight into Pathogenesis, Genome Evolution and Niche Adaptation, and Infection Detection PLoS ONE Soo Jeon Choi, Annа K. Snyder et al. 23
18 Disrupting theluxSquorum sensing gene does not significantly affectBacillus anthracisvirulence in mice or guinea pigs Virulence Joel A. Bozue, Bradford S. Powell et al. 6
19 The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis Microbial Pathogenesis Joel A. Bozue, Sherry Mou et al. 33
20 A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies Journal of Microbiological Methods Susan L. Welkos, Christopher K. Cote et al. 42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026